Skip to content
Search

Latest Stories

Submit Guest Post

Five more West Indies squad members test positive for Covid

Five more West Indies squad members test positive for Covid

FIVE more members of the West Indies cricket squad - including three players - have tested positive for Covid, officials said Thursday (16), leaving the rest of their Pakistan tour hanging in the balance.

Four members of the touring party tested positive on Saturday (11), bringing the total to nine since they arrived last week for a Twenty20 and ODI series.


Cricket West Indies officials said they would meet with their Pakistan counterparts "once all members of the touring party have been tested again" to determine whether they can continue.

Any cancellation would be a huge blow to Pakistan, which has seen tours by New Zealand and England called off in recent months on security grounds.

Pakistan won the first two Twenty20 matches against the West Indies with dead rubber to be due to be played later Thursday (16).

The three ODIs are scheduled for December 18, 20 and 22.

West Indies officials said the latest positive test results in the squad came from wicketkeeper-batsman Shai Hope, left-arm spinner Akeal Hosein, all-rounder Justin Greaves, assistant coach Roddy Estwick, and physician Akshai Mansingh.

Left-arm pace bowler Sheldon Cottrell and all-rounders Roston Chase and Kyle Mayers, tested positive for Covid-19 on Saturday, along with a team official.

(AFP)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Hair Loss risks

Popular GLP-1 weight loss drugs are facing fresh scrutiny over reports of hair loss.

iStock

Hair loss risk up by 68 per cent? New study puts GLP-1 drugs under the spotlight

  • Researchers found GLP-1 drugs were associated with up to a 68 per cent higher risk of hair loss than some other diabetes medicines.
  • UK regulators have received more than 1,200 reports of hair loss linked to semaglutide and tirzepatide since last year.
  • Experts say rapid weight loss may be the most likely explanation, but further research is needed.

Popular GLP-1 weight loss drugs such as Mounjaro, Ozempic and Wegovy are under fresh scrutiny after a major study found they may be linked to a higher risk of hair loss. The findings add to a growing number of reports already being reviewed by health regulators in both the UK and the US, although researchers say more evidence is needed before any direct link can be confirmed.

The study, published in the British Medical Journal (BMJ), analysed health records from around 50,000 adults and compared people taking GLP-1 receptor agonists with those using other medicines to manage type 2 diabetes. Researchers found that people using GLP-1 drugs had a 37 per cent higher risk of developing alopecia than those taking SGLT-2 inhibitors, while the risk was 68 per cent higher compared with people using DPP-4 inhibitors.

Keep ReadingShow less